Product Information

GABAPENTIN 250 MG/5 ML SOLN is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0887 per ML under NDC 31722006947. Its NADAC has been published 103 times since Sep 4, 2024.

FDA first approved this application on Jan 17, 2024. Its Orange Book therapeutic-equivalence code is AA.

The High Outlier badge above means this manufacturer's average price in the GABAPENTIN market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

GABAPENTIN 250 MG/5 ML SOLN

GABAPENTIN
$0.0887per ML
High Outlier

Strength

250 mg/5mL

NDC

31722006947

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

GABAPENTIN

Approval Type

Generic (ANDA)

FDA Application

ANDA217682

FDA Approved

1/17/2024

TE Code

AA

On Market Since

1/17/2024

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for GABAPENTIN 250 MG/5 ML SOLN has been published 103 times since Sep 4, 2024, and over the history we have for it it has declined 29.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0887 per ML
All-time high$0.1257 (Sep 11, 2024)
All-time low$0.0768 (Nov 20, 2024)
52-week high$0.0895
52-week low$0.0825
Median price$0.0863
Average price$0.0889
Largest weekly change-19.0% (Nov 20, 2024)
Weeks tracked103
Tracking sinceSep 4, 2024

Price History

1W

+3.0%

1M

+7.4%

3M

+5.7%

6M

+4.0%

1Y

+0.5%

3Y

N/A

5Y

N/A

All

-29.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the GABAPENTIN market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of GABAPENTIN 250 MG/5 ML SOLN?

The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 250 MG/5 ML SOLN, manufactured by Camber Pharmaceuticals Inc., is $0.0887 per ML (NDC 31722006947), effective Aug 19, 2026.

How has the price of GABAPENTIN 250 MG/5 ML SOLN changed over time?

Over the history we have for it, the NADAC for GABAPENTIN 250 MG/5 ML SOLN has declined 29.5%. It has been tracked across 103 weekly CMS publications since Sep 4, 2024.

What are the highest and lowest recorded NADAC prices for GABAPENTIN 250 MG/5 ML SOLN?

Since Sep 4, 2024, the NADAC for GABAPENTIN 250 MG/5 ML SOLN has ranged from a low of $0.0768 (Nov 20, 2024) to a high of $0.1257 (Sep 11, 2024), with a median of $0.0863 per ML.

Are there cheaper alternatives to GABAPENTIN 250 MG/5 ML SOLN?

No other NADAC-published product currently shares the active ingredient and strength of GABAPENTIN 250 MG/5 ML SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures GABAPENTIN 250 MG/5 ML SOLN?

GABAPENTIN 250 MG/5 ML SOLN (NDC 31722006947) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.